Ordering Recommendation
Not recommended as a stand-alone test. The preferred test for HCV screening and diagnosis is Hepatitis C Virus Antibody by CIA with Reflex to HCV by Quantitative NAAT (2010784). If the patient is immunocompromised or if acute HCV infection is suspected, the recommended test is Hepatitis C Virus (HCV) by Quantitative NAAT (3000572).
Mnemonic
Methodology
Qualitative Chemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
New York DOH Approval Status
Specimen Required
Serum Separator Tube (SST). Also acceptable: Lavender (EDTA) or Pink (K2EDTA).
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Refrigerated.
Specimens containing particulate material. Severely hemolyzed, heat-inactivated, or lipemic specimens. Heparinized plasma.
After separation from cells: Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Indefinitely (avoid freeze/thaw cycles)
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
Hepatitis C Antibody by CIA Interp | Negative |
Interpretive Data
This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
Components |
Interpretation |
---|---|
Hepatitis C Antibody by CIA Index | 0.79 IV or less Negative 0.80 to 0.99 IV Equivocal 1.00 to 10.99 IV Low Positive 11.00 IV or greater High Positive |
FDA
Note
For both low-positive and high-positive anti-HCV screening results, ARUP recommends collecting a new specimen and testing for Hepatitis C RNA by PCR to rule out active infection.
Hotline History
CPT Codes
86803
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0020099 | Hepatitis C Antibody by CIA Interp | 13955-0 |
2002404 | Hepatitis C Antibody by CIA Index | 57006-9 |
Aliases
- Anti-HCV
- HCV Ab
- HCV Antibody
- HCVAB, Serum
- Hepatitis C Viral Antibody, Serum
- non-A, non-B Hepatitis